Exact Sciences
EXAS
#1169
Rank
A$28.15 B
Marketcap
A$147.49
Share price
0.00%
Change (1 day)
82.34%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.48. In 2024 the company made an earnings per share (EPS) of A-$7.83.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.549.05%
2024A-$7.83
2022A-$4.982.31%
2021A-$4.86-38.54%
2020A-$7.92692.96%
2019A-$1.00-50.69%
2018A-$2.0244%
2017A-$1.41-39.39%
2016A-$2.32-2.94%
2015A-$2.3937.1%
2014A-$1.7479.71%
2013A-$0.97-21.59%
2012A-$1.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$3.60-148.11%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$1.56-120.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.48-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.05-19.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$71.56 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA